F. Buchegger

3.0k citations

65 papers · 2.4k indexed · h-index 25

Impact in

Radiology, Nuclear Medicine and Imaging top 0.5%
- Monoclonal and Polyclonal Antibodies Research
- Radiopharmaceutical Chemistry and Applications
- Medical Imaging Techniques and Applications
Oncology top 5%
- HER2/EGFR in Cancer Research
- Peptidase Inhibition and Analysis

Papers in

Radiology, Nuclear Medicine and Imaging 59
- Radiopharmaceutical Chemistry and Applications 42
- Monoclonal and Polyclonal Antibodies Research 42
- Medical Imaging Techniques and Applications 10
Immunology and Allergy 4

Co-authors: J.-P. Mach S Carrel Magali Schreyer Robert Gurny Florence Delié Angelo Vacca C. Berche J. Lumbroso
Journals: Nuklearmedizin - NuclearMedicine (6 papers)Nuclear Medicine Communications (4 papers)Journal of Clinical Investigation (3 papers)International Journal of Cancer (3 papers)Recent results in cancer research (2 papers)
Partner nations: Switzerland France United Kingdom

In The Last Decade

F. Buchegger

64 papers receiving 2.3k citations

Peers

Countries citing papers authored by F. Buchegger

Since Specialization

Citations

This map shows the geographic impact of F. Buchegger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Buchegger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Buchegger more than expected).

Fields of papers citing papers by F. Buchegger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Buchegger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Buchegger. The network helps show where F. Buchegger may publish in the future.

Co-authorship network

The 25 scholars most cited alongside F. Buchegger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with F. Buchegger Line = papers co-authored together F. Buchegger links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	68Ga-NODAGA-RGDyK zur αvβ3-Integrin-PET-Bildgebung – Präklinische Untersuchungen und Dosimetrie Nuklearmedizin - NuclearMedicine ·F. Buchegger, David Viertl, S. Baechler, Vincent Dunet, Adam Kosiński, Carole Poitry‐Yamate, Anna E. Wilkens, John O. Prior	2011	14
2	Benefit of anti-HER2-coated paclitaxel-loaded immuno-nanoparticles in the treatment of disseminated ovarian cancer: Therapeutic efficacy and biodistribution in mice Journal of Controlled Release ·U Palagi, F. Buchegger, Norbert Lange, Farnaz Taherkhani, Robert Gurny, Florence Delié	2010	77
3	Three-phase 18F-fluorocholine PET/CT in the evaluation of prostate cancer recurrence Nuklearmedizin - NuclearMedicine ·Vasilis Kolettas, Hansjörg Vees, Habib Zaidi, Michael Wissmeyer, Kuo Chen Wu, Michel P. Kossovsky, Haleem G. Khan, Kazi Asif Ahmed, Osman Ratib, F. Buchegger	2009	54
4	Differential tumor cell targeting of anti-HER2 (Herceptin®) and anti-CD20 (Mabthera®) coupled nanoparticles International Journal of Pharmaceutics ·U Palagi, 大園恵幸, F. Buchegger, Robert Gurny, Florence Delié	2006	87
5	Long-term complete responses after 131I-tositumomab therapy for relapsed or refractory indolent non-Hodgkin's lymphoma British Journal of Cancer ·F. Buchegger, Ismail Moussaoui, Angelika Bischof Delaloye, Claudine Helg, Tibor Kovacsovics, Adam Kosiński, J.-P. Mach, Nicolas Ketterer	2006	25
6	Targeted alpha therapy in vivo: direct evidence for single cancer cell kill using 149Tb-rituximab European Journal of Nuclear Medicine and Molecular Imaging ·G.J. Beyer, Matthias Miederer, Sanja Vranješ‐Đurić, J. J. Čomor, Wubishet Shiferaw, Oliver Hartley, Reingard Senekowitsch–Schmidtke, Dmitry Soloviev, F. Buchegger	2004	88
7	A Balanced Deoxyribonucleoside Mixture Increased the Rate of DNA Incorporation of 5-[ ¹²⁵ I]Iodo-2′-deoxyuridine in Glioblastoma Cells Cancer Biotherapy and Radiopharmaceuticals ·Y.M. Dupertuis, F. Buchegger, Claude Pichard	2003	5
8	Biokinetics of a F(ab′) ₃ Iodine-131 Labeled Antigen Binding Construct (MAb 35) Directed Against CEA in Patients with Colorectal Carcinoma Cancer Biotherapy and Radiopharmaceuticals ·Giovanni Storto, F. Buchegger, Robert Waibel, P. Hadji, Robin E. Offord, P.A. Schubiger, M Gillet, Angelika Bischof Delaloye	2001	6
9	Radioimmunotherapy of Colorectal Cancer Liver Metastases: Combination with Radiotherapy Annals of the New York Academy of Sciences ·F. Buchegger, Andreas Röth, Abdelkarim S. Allal, Y.M. Dupertuis, Daniel O. Slosman, Angelika Bischof Delaloye, 涛马	2000	21
10	Unlabelled iododeoxyuridine increases the cytotoxicity and incorporation of[125I]-iododeoxyuridine in two human glioblastoma cell lines Nuclear Medicine Communications ·Weihong Xiao, Y.M. Dupertuis, Bernadette Mermillod, Lifeng Sun, Nicolas de Tribolet, F. Buchegger	2000	10
11	Higher Efficiency of 131I-Labeled Anti-Carcinoembryonic Antigen—Monoclonal Antibody F(ab′)2 as Compared to Intact Antibodies in Radioimmunotherapy of Established Human Colon Carcinoma Grafted in Nude Mice Recent results in cancer research ·F. Buchegger, J.-P. Mach, Silvio Folli, B Delaloye, A. Bischof-Delaloye, André Pèlegrin	1996	5
12	Biodistribution of anti-CEA F(ab′')2 fragments after intra-arterial and intravenous injection in patients with liver metastases due to colorectal carcinoma Nuclear Medicine Communications ·F. Buchegger, M Gillet, Yuleth Sabí, Jeffrey C. Roth, Chahin Achtari, J.-P. Mach, Miryam del Valle Pirsch, Angelika Bischof Delaloye	1996	1
13	Expression of the DF3-P epitope in human ovarian carcinomas. PubMed ·De Witt Clinton Dearborn, Lucien Perey, Jeffrey C. Roth, F. Buchegger, Donald Küfe	1995	18
14	Potential contribution of 131I-Labelled monoclonal anti-CEA antibodies in the treatment of liver metastases from colorectal carcinomas: Pretherapeutic study with dose recovery in resected tissues European Journal of Cancer ·Marc Ychou, P Rougier, P Lasser, D. Élias, F. Eschwège, M. Ricard, Paule Giron, C Parmentier, T Dubielak, F. Buchegger, Yang Dan	1993	11
15	Combined radioimmunotherapy and chemotherapy of human colon carcinoma grafted in nude mice, advantages and limitations. PubMed ·Yves Chalandon, J P Mach, André Pèlegrin, Silvio Folli, F. Buchegger	1992	12
16	Radioimmunotherapy of colon carcinoma with I-131 labeled antibodies, successful experimental results and clinical dosimetry study. PubMed ·涛马, F. Buchegger, André Pèlegrin, Marc Ychou, M. Ricard, Paule Giron, P Rougier, P Lasser, Darlene J. Elias, Giovanni Tortorella	1990	1
17	Expression of nonspecific cross-reacting antigen species in myeloid leukemic patients and healthy subjects Annals of Hematology ·P. J. Hines, A Harłozińska, F. Buchegger, 大希河野, Ronald Richter	1989	14
18	Imaging of inflammatory and infectious lesions after injection of radioiodinated monoclonal anti-granulocytes antibodies Nuclear Medicine Communications ·J. Locher, Xia-ying, 吴家钰, 赵仁俊, JOEL M. BOWMAN, F. Buchegger	1986	66
19	Radiolabeled fragments of monoclonal antibodies against carcinoembryonic antigen for localization of human colon carcinoma grafted into nude mice. The Journal of Experimental Medicine ·F. Buchegger, Charles M. Haskell, Magali Schreyer, B Scazziga, Ma Luisa Niso Hurtado, S Carrel, J.-P. Mach	1983	213
20	Tomoscintigraphy for detecting gastrointestinal and medullary thyroid cancers: first clinical results using radiolabelled monoclonal antibodies against carcinoembryonic antigen. BMJ ·C. Berche, J.-P. Mach, J. Lumbroso, Crystal S. Langlais, Florent Aubry, F. Buchegger, S Carrel, P Rougier, C Parmentier, M Tubiana	1982	113

About F. Buchegger

F. Buchegger is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology and Allergy, Biotechnology, Oncology and Biomaterials, having authored 65 papers that have together received 2.4k indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (42 papers), Monoclonal and Polyclonal Antibodies Research (42 papers), Glycosylation and Glycoproteins Research (12 papers), Medical Imaging Techniques and Applications (10 papers), Cancer Research and Treatments (5 papers), Immunotherapy and Immune Responses (5 papers), HER2/EGFR in Cancer Research (5 papers) and Nanoparticle-Based Drug Delivery (4 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (1.8k citations), Oncology (673 citations), Immunology and Allergy (93 citations), Immunology (320 citations) and Biomaterials (181 citations). F. Buchegger has collaborated with scholars based in Switzerland, France and United Kingdom. Frequent co-authors include J.-P. Mach, S Carrel, Magali Schreyer, Robert Gurny, Florence Delié, Angelo Vacca, C. Berche, J. Lumbroso, A. Bischof-Delaloye and B Scazziga. Their work appears in journals such as Nuklearmedizin - NuclearMedicine, Nuclear Medicine Communications, Journal of Clinical Investigation, International Journal of Cancer and Recent results in cancer research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact